SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 9 of 26
Word Count: 1430
Character Count: 8882

Document Content:

gain or loss to holders for federal income tax purposes. “U.S. Government Obligations” means direct obligations of the United States or any agency or instrumentality of the United States, the payment of which is unconditionally guaranteed by the United States, which, in either case, have the full faith and credit of the United States pledged for payment and which are not callable at the issuer’s option, or certificates representing an ownership interest in such obligations. Regarding the Trustee Unless otherwise indicated in a prospectus supplement, the trustee will also act as depository of funds, transfer agent, paying agent and conversion agent, as applicable, with respect to the debt securities. In certain circumstances, we or the securityholders may remove the trustee as the trustee under a given indenture. The indenture trustee may also provide additional unrelated services to us as a depository of funds, registrar, trustee and similar services. Governing Law

The indentures and the debt
securities will be governed by New York law, except to the extent that the Trust Indenture Act of 1939 is applicable.

DESCRIPTION OF STOCK WARRANTS

We summarize below some of
the provisions that will apply to the warrants unless the applicable prospectus supplement provides otherwise. This summary may not contain
all information that is important to you. The complete terms of the warrants will be contained in the applicable warrant certificate and
warrant agreement. These documents have been or will be included or incorporated by reference as exhibits to the registration statement
of which this prospectus is a part. You should read the warrant certificate and the warrant agreement. You should also read the prospectus
supplement, which will contain additional information and which may update or change some of the information below.

General

We may issue, together with
common or preferred stock as units or separately, warrants for the purchase of shares of our common or preferred stock. The terms of each
warrant will be discussed in the applicable prospectus supplement relating to the particular series of warrants. The form(s) of certificate
representing the warrants and/or the warrant agreement will be, in each case, filed with the SEC as an exhibit to a document incorporated
by reference in the registration statement of which this prospectus is a part on or prior to the date of any prospectus supplement relating
to an offering of the particular warrant. The following summary of material provisions of the warrants and the warrant agreements are
subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable
to a particular series of warrants.

The prospectus supplement
relating to any series of warrants that are offered by this prospectus will describe, among other things, the following terms to the extent
they are applicable to that series of warrants:

●	the procedures and conditions relating to the exercise of the warrants;

●	the number of shares of our common or preferred stock, if any, issued with the warrants;

●	the date, if any, on and after which the warrants and any related shares of our common or preferred stock will be separately transferable;

●	the offering price of the warrants, if any;

●	the number of shares of our common or preferred stock which may be purchased upon exercise of the warrants and the price or prices at which the shares may be purchased upon exercise;

●	the date on which the right to exercise the warrants will begin and the date on which the right will expire;

●	a discussion of the material United States federal income tax considerations applicable to the exercise of the warrants;

●	anti-dilution provisions of the warrants, if any;

●	call provisions of the warrants, if any; and

●	any other material terms of the warrants.

Each warrant may entitle the
holder to purchase for cash, or, in limited circumstances, by effecting a cashless exercise for, the number of shares of our common or
preferred stock at the exercise price that is described in the applicable prospectus supplement. Warrants will be exercisable during the
period of time described in the applicable prospectus supplement. After that period, unexercised warrants will be void. Warrants may be
exercised in the manner described in the applicable prospectus supplement.

A holder of a warrant will
not have any of the rights of a holder of our common or preferred stock before the stock is purchased upon exercise of the warrant. Therefore,
before a warrant is exercised, the holder of the warrant will not be entitled to receive any dividend payments or exercise any voting
or other rights associated with shares of our common or preferred stock which may be purchased when the warrant is exercised.

Transfer Agent and Registrar

The transfer agent and registrar,
if any, for any warrants will be set forth in the applicable prospectus supplement.

DESCRIPTION OF SUBSCRIPTION RIGHTS

We may issue subscription
rights to purchase our equity securities or debt securities. These subscription rights may be offered independently or together with any
other security offered hereby and may or may not be transferable by the stockholder receiving the subscription rights in such offering.
In connection with any offering of subscription rights, we may enter into a standby arrangement with one or more underwriters or other
purchasers pursuant to which the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for
after such offering.

The prospectus supplement
relating to any subscription rights we offer, if any, will, to the extent applicable, include specific terms relating to the offering,
including some or all of the following:

●	the price, if any, for the subscription rights;

●	the exercise price payable for our equity securities or debt securities upon the exercise of the subscription rights;

●	the number of subscription rights to be issued to each stockholder;

●	the number and terms of our equity securities and debt securities which may be purchased per each subscription right;

●	the extent to which the subscription rights are transferable;

●	any other terms of the subscription rights, including the terms, procedures and limitations relating to the exchange and exercise of the subscription rights;

●	the date on which the right to exercise the subscription rights shall commence, and the date on which the subscription rights shall expire;

●	the extent to which the subscription rights may include an over-subscription privilege with respect to unsubscribed securities or an over-allotment privilege to the extent the securities are fully subscribed; and

●	if applicable, the material terms of any standby underwriting or purchase arrangement which may be entered into by us in connection with the offering of subscription rights.

DESCRIPTION OF UNITS

We may issue units comprised
of one or more of the other securities described in this prospectus in any combination. Each unit will be issued so that the holder of
the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of
a holder of each included security (but, to the extent convertible securities are included in the units, the holder of the units will
be deemed the holder of the convertible securities and not the holder of the underlying securities). The unit agreement under which a
unit is issued, if any, may provide that the securities included in the unit may not be held or transferred separately, at any time or
at any time before a specified date. The applicable prospectus supplement may describe:

●	the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

●	any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units;

●	the terms of the unit agreement governing the units;

●	United States federal income tax considerations relevant to the units; and

●	whether the units will be issued in fully registered global form.

This summary of certain general
terms of units and any summary description of units in the applicable prospectus supplement do not purport to be complete and are qualified
in their entirety by reference to all provisions of the applicable unit agreement and, if applicable, collateral arrangements and depositary
arrangements relating to such units. The forms of the unit agreements and other documents relating to a particular issue of units will
be filed with the SEC each time we issue units, and you should read those documents for provisions that may be important to you.

FORMS OF SECURITIES